Form 8-K - Current report:
SEC Accession No. 0001104659-24-122574
Filing Date
2024-11-25
Accepted
2024-11-25 16:15:18
Documents
13
Period of Report
2024-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429498d1_8k.htm   iXBRL 8-K 29545
  Complete submission text file 0001104659-24-122574.txt   203716

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bpth-20241119.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20241119_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20241119_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2429498d1_8k_htm.xml XML 3700
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 241496093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)